First Manhattan’s ROCK CREEK PHARMACEUTICALS INC COM STK (DE) RCPI Stock Holding History

First Manhattan’s Portfolio RCPI Stock Details RCPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-400	Closed	–	–	1561
2015 Q3	$0	Hold	400	–	–	﹤0.01%	1548
2015 Q2	$0	Hold	400	–	–	﹤0.01%	1557
2015 Q1	$1K	Hold	400	–	–	﹤0.01%	1428
2014 Q4	$1K	Hold	400	–	–	﹤0.01%	1460
2014 Q3	$2K	Hold	400	–	–	﹤0.01%	1395
2014 Q2	$5K	Buy	+400	New	+$6.94K	﹤0.01%	1289

Other funds holding RCPI

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

KCM

Kempner Capital Management Galveston, Texas $106M AUM 29.1% 1-Year Est. Return

WealthPLAN Partners Omaha, Nebraska $518M AUM 17.96% 1-Year Est. Return

IWMPD

Integrated Wealth Management (Palm Desert) Palm Desert, California $299M AUM 12.85% 1-Year Est. Return

First Manhattan's RCPI Position: Q4 2015 in Review

First Manhattan sold out of ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) in Q4 2015, closing a stake of 400 shares.

First Manhattan first reported a position in RCPI in Q2 2014 and held it in 6 quarters. The position peaked at $5K in Q2 2014. 9 funds tracked by Wall St. Rank hold RCPI as of Q4 2015.

First Manhattan reported no remaining ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position as of Q4 2015 after selling out during the quarter.
First Manhattan sold 400 ROCK CREEK PHARMACEUTICALS INC COM STK (DE) shares in Q4 2015.
First Manhattan first reported a position in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) in Q2 2014 and held it in 6 quarters.
First Manhattan's ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position peaked at $5K in Q2 2014.
9 funds tracked by Wall St. Rank held ROCK CREEK PHARMACEUTICALS INC COM STK (DE) as of Q4 2015.

Based on First Manhattan's 13F filing for Q4 2015, filed 20 Jan 2016.